Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of December 31, 2025, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 900 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.
What We Do:
We’ve taken three pillars of the P&C industry – EDI clearinghouse network, document mailroom intake, and electronic payments processing – and integrated them into a seamless solution to meet our client’s needs and goals. Our uniquely integrated automation solutions provide organizations flexibility and modularization; creating a purpose-built, bi-lateral network that can be implemented today while easily adjusting to future-state direction and growth.
As an EDI clearinghouse we are a single source, all-payor partner for eBilling services in the P&C market, flexibly routing bills and attachments through pre-adjudication edits that produce faster processing timelines and payments.
Our digital mailroom solution automates document-driven processing functions, enabling enterprises to focus on their core business competencies.
Data Dimensions also offers a variety of integrated payment options for payers and payees to issue and accept payments and remittance exchanges while reducing administrative costs using an enhanced cascading payment modality process.
For more information and a complete list of services, visit www.datadimensions.com.
Neural Analytics, Inc. is a medical robotics company developing and commercializing technologies to measure and track brain health. Our Lucid™ Robotic System is a combination of the Lucid™ M1 Transcranial Doppler Ultrasound System, an all-in-one neurovascular ultrasound device designed to non-invasively measure and display brain blood flow information, with NeuralBot™, a medical robotic headset which automatically adjusts orientation and position to collect blood flow data under the guidance of a healthcare professional. It integrates ultrasound, robotics and machine learning.
The robotic ultrasound technology enables clinicians to noninvasively monitor a patient’s brain blood flow characteristics and provide critical information to help diagnose neurological disorders such as stroke. It can be employed throughout the stroke care chain from initial assessment to post intervention recovery monitoring.
The Lucid Robotic System is cleared by the FDA and approved by EU regulatory authorities.